The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels

Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects

(2012) Ana-Lucia A Kater et al.   Diabetology & Metabolic Syndrome

Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia

(2011) Shusuke Yagi et al.   Journal of Atherosclerosis and Thrombosis

Inflammation in Atherosclerosis:

(2010) Peter Libby et al.   CIRCULATION JOURNAL

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

(2010) D. C. Chan et al.   DIABETES CARE

Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease

(2010) Milan Gupta et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

The Effect of Simvastatin on Lymphocyte Secretory Function in Patients With Impaired Fasting Glucose

(2010) Robert Krysiak et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect

(2009) D Gómez-Garre et al.   BRITISH JOURNAL OF PHARMACOLOGY

Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract

(2009) T. Filippatos et al.   CURRENT PHARMACEUTICAL DESIGN

Inflammatory mechanisms in atherosclerosis

(2009) G. K. HANSSON   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients in vitro

(2009) Steven M. Shaw et al.   TRANSPLANT IMMUNOLOGY

Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice

(2008) Peter J. Kuhlencordt et al.   ATHEROSCLEROSIS

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: A 12-week, multicenter, randomized, open-label, parallel-group study

(2008) Luis A. Alvarez-Sala et al.   CLINICAL THERAPEUTICS

Novel nonstatin strategies to lower low-density lipoprotein cholesterol

(2008) Michael H. Davidson   Current Atherosclerosis Reports

T cells in arteritis and atherosclerosis

(2008) Cornelia M Weyand et al.   CURRENT OPINION IN LIPIDOLOGY

Ezetimibe, a Selective Inhibitor of the Transport of Cholesterol

(2008) Shin-ichiro Miura et al.   INTERNAL MEDICINE

Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes

(2008) Jerome L. Fleg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

(2008) Anne B. Rossebø et al.   NEW ENGLAND JOURNAL OF MEDICINE

Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

(2008) John J.P. Kastelein et al.   NEW ENGLAND JOURNAL OF MEDICINE

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis

(2007) Dirk Reinhold   Frontiers in Bioscience-Landmark